STALLION Stallion India Fluorochemicals Q3 FY26 results (Oct–Dec 2025) and concall
Stallion India Fluorochemicals reported strong Q3 and 9M FY26 results, with revenue growing 23.2% and 41.7% YoY respectively, and 9M PAT surging 72.8%. The company achieved key milestones including environmental clearance for its 10,000 MT R-32 plant in Bhilwara and strategic partnerships for helium. However, commissioning of Khalapur and Mambattu facilities faced delays due to re-engineering and material imports, pushing timelines to Q4 FY26. Funding for the R32 plant was secured through a promoter share sale after a preferential issue failed due to market volatility.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q3 FY26: revenue up 23.5%, net profit up 10.0% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 |
|---|---|---|---|---|---|---|
| Revenue | 68 | 85 | 152 | 110 | 106 +56% | 105 +24% |
| EBITDA | 2 | 14 | 19 | 14 | 16 +700% | 12 −14% |
| Net profit | 1 | 10 | 13 | 10 | 11 +1000% | 11 +10% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
